HISTONE DEACETYLASE INHIBITOR
Farydak, also known by its drug name, Panobinostat, is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma in people who have tried other therapies. Farydak is usually combined with Velcade and a corticosteroid.
Farydak is an anticancer drug. Farydak is a member of a class of drugs called histone deacetylase inhibitors. Farydak is believed to work by killing cancer cells and slowing their growth.
How do I take it?
Farydak is taken three times per week on a specific schedule.
Farydak is available as a capsule.
The FDA-approved label for Farydak lists common side effects including fatigue, fever, nausea, vomiting, diarrhea, loss of appetite, and swelling in the extremities.
Rare but serious side effects listed for Farydak include liver damage, fetal harm in pregnant women, and potentially life-threatening bleeding in the lungs or gastrointestinal tract.
For more details about this treatment, visit:
Farydak – Novartis
Drug Therapy for Multiple Myeloma – American Cancer Society